Efficacy and mechanism of intermittent fasting in metabolic associated fatty liver disease based on ultraperformance liquid chromatography-tandem mass spectrometry

OBJECTIVES: Drug treatment of metabolic associated fatty liver disease (MAFLD) remains lacking. This study analyzes the efficacy and mechanism underlying intermittent fasting combined with lipidomics. METHODS: Thirty-two male rats were randomly divided into three groups: Normal group, administered a...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Jiang, Feng, Dandan, Jia, Xiaoli, Zhai, Song, Liu, Yixin, Gao, Ning, Zhang, Xin, Li, Mei, Lu, Mengnan, Liu, Chenrui, Dang, Shuangsuo, Shi, Juanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704542/
https://www.ncbi.nlm.nih.gov/pubmed/36451744
http://dx.doi.org/10.3389/fnut.2022.838091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704542/
https://www.ncbi.nlm.nih.gov/pubmed/36451744
http://dx.doi.org/10.3389/fnut.2022.838091

Ejemplares similares